Skip to content
Peptigraph home

Is BPC-157 Legal? FDA, Compounding and WADA Status

BPC-157's FDA status, compounding rules and anti-doping status, with a dated timeline of every change we track.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureGastric pentadecapeptideUpdated
FDA status
Not approved
Off Category 2, 15 Apr 2026
PCAC vote
8–6 for 503A
Jul 2026, not final
WADA
Prohibited (S0)
In and out of competition
Not legal adviceStatus reflects public FDA and WADA records on the date shown. Rules differ by country and state.

Current status

PCAC voted 8–6 for 503A (Jul 2026)

No. BPC-157 is not FDA approved for any use. The FDA removed it from Category 2 on 15 Apr 2026. Its advisory committee voted 8–6 in July 2026 to add it to the 503A compounding list. That vote is not final.

BPC-157: regulatory status by country
CountryStatusSource
United StatesNo approved product foundNo FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "BPC-157" returned no matches on 2 Oct 2026.api.fda.govchecked 2 Oct 2026

Timeline

  1. Advisory committee backs 6 of 7 peptides for the 503A listPCAC vote
  2. FDA gives notice that 12 peptides will be removed from Category 2 (nominations withdrawn)FDA
Every peptide on the FDA tracker

Compounding and research-use sellers

  • Category 2 is the FDA's list of bulk substances it flagged as raising significant safety concerns. Compounding pharmacies are not expected to compound from them while they are on it.
  • The Pharmacy Compounding Advisory Committee (PCAC) advises the FDA on which substances belong on the 503A bulks list that pharmacies may compound from. Its votes are advice; the FDA decides.
  • "Research use only" products are sold outside these rules and are not checked by the FDA for identity, purity or dose.
  • BPC-157 was removed from Category 2 on 15 Apr 2026. Removal is not approval.

FDA compounding record: BPC-157 was removed from FDA's 503A category 2 because the nominators withdrew; FDA announced a Pharmacy Compounding Advisory Committee consultation on 23 July 2026 on whether to add it to the 503A bulks list. · fda.gov, checked 2 Oct 2026

Sport and drug testing

Prohibited by WADA (S0)

BPC-157 is named in S0 (non-approved substances), prohibited at all times, in and out of competition.

Outside the US

Rules differ by country. What each regulator's own records show, with the date we checked:

BPC-157: regulatory status by country
CountryStatusSource
United KingdomNo approved product foundNo approved product found in an emc (UK SmPC compendium) search for "BPC-157" on 2 Oct 2026.medicines.org.ukchecked 2 Oct 2026
CanadaNo approved product foundNo product found in a Health Canada Drug Product Database search for ingredient "BPC-157" on 2 Oct 2026.health-products.canada.cachecked 2 Oct 2026
European UnionNo centrally authorised EU medicine foundEMA medicines list, searched 2 Oct 2026ema.europa.euchecked 2 Oct 2026

What FDA records say about BPC-157

FDA Drugs@FDA returns nothing for the active ingredient BPC-157: the query in the cached record came back as not found.[4]

In FDA’s safety-risk table for withdrawn nominations, the BPC-157 entry says the agency found little safety information and cannot tell whether the drug would harm people.[11]

The same entry flags immunogenicity and peptide-related impurities as concerns for compounded BPC-157.[11]

FDA describes Category 2 as the tier for nominated substances where it has identified significant safety risks in compounding pending further evaluation; unlike Category 1, FDA does not intend to adopt the Category 1 policy for them.[12]

What changed in 2026

In April, FDA gave notice that BPC-157 would leave Category 2 because the nominations were withdrawn by the nominators, while announcing a PCAC consultation on 23 July 2026 about BPC-157 acetate and the free base.[13]

FDA elected to proceed with presenting BPC-157 free base and BPC-157 acetate to the PCAC even though the nominations had been withdrawn.[14]

FDA's meeting page lists ulcerative colitis as the use evaluated for BPC-157 free base and acetate.[15]

FDA staff went into the meeting proposing that the free base not go on the 503A list.[14]

The committee was asked to vote on whether BPC-157 acetate should be placed on the list, separately from the free base.[16]

What is still pending

FDA said it will not issue a final determination until the advisory committee input has been considered and all reviews have been finalized.[14]

Under 503A, a bulk substance must meet a USP or NF monograph, be a component of an FDA-approved drug, or appear on the 503A bulks list. For BPC-157 only the last route is open.[12]

Sport

WADA names BPC-157 in S0, the class of non-approved substances prohibited at all times.[3]

Common questions

Is BPC-157 FDA approved?

No. FDA’s drug database search returned no match, and the EMA medicines export lists no BPC-157 medicine.[8]

Is BPC-157 legal to buy?

BPC-157 is not an approved drug: FDA's slides state it is not a component of an approved product in any country. Whether it can be compounded is unsettled, because FDA has treated it as a safety-risk substance and the bulks-list decision is still pending (see the sections above). WADA separately prohibits it for athletes.[17]

Is BPC-157 banned by WADA?

Yes. Prohibited by WADA (S0), in and out of competition.

Did FDA ban BPC-157?

FDA did not ban it in the records here. It listed BPC-157 as a safety-risk substance, then gave notice of removal after the nominators withdrew; that tier means FDA would consider enforcement against compounders, not that a ban order was issued.[12]

Is BPC-157 in Category 1?

The April notice lists BPC-157 under removals from the safety-risk category and then announces a PCAC consultation. It does not add the substance to the list under evaluation.[13]

Is BPC-157 legal in the UK?

The UK's electronic medicines compendium returned no search results for BPC-157, so no UK-licensed BPC-157 medicine turned up there. That is a statement about licensed products and says nothing about possession or sale law.[6]

More on BPC-157

Sources

  1. 1Certain bulk drug substances for use in compounding that may present significant safety risks (Category 2; 'nominated but withdrawn' table, content current as of 22 Apr 2026)U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
  2. 2Pharmacy Compounding Advisory Committee meeting, 23–24 Jul 2026 (agenda and materials)U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
  3. 3World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  4. 4United States: No FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "BPC-157" returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
  5. 5US compounding: BPC-157 was removed from FDA's 503A category 2 because the nominators withdrew; FDA announced a Pharmacy Compounding Advisory Committee consultation on 23 July 2026 on whether to add it to the 503A bulks list.U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
  6. 6United Kingdom: No approved product found in an emc (UK SmPC compendium) search for "BPC-157" on 2 Oct 2026.Electronic Medicines Compendium (UK) · 2026medicines.org.ukAccessed 2 Oct 2026
  7. 7Canada: No product found in a Health Canada Drug Product Database search for ingredient "BPC-157" on 2 Oct 2026.Health Canada · 2026health-products.canada.caAccessed 2 Oct 2026
  8. 8EMA medicines export (centrally authorised medicines) (searched 2 Oct 2026)European Medicines Agency · 2026ema.europa.euAccessed 2 Oct 2026
  9. 9Advisory committee backs 6 of 7 peptides for the 503A listNCPA · 2026ncpa.org
  10. 10FDA gives notice that 12 peptides will be removed from Category 2 (nominations withdrawn)FDA · 2026fda.govAccessed 2 Oct 2026
  11. 11Official web pageOfficial web page · web page
  12. 12Official web pageOfficial web page · web page
  13. 13Official web pageOfficial web page · web page
  14. 14Official web pageOfficial web page · web page
  15. 15Official web pageOfficial web page · web page
  16. 16Official web pageOfficial web page · web page
  17. 17Official web pageOfficial web page · web page

Found an error? Report a correction.